Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis

Cell Reports
Nathan L PriceCarlos Fernández-Hernando

Abstract

As an important regulator of macrophage cholesterol efflux and HDL biogenesis, miR-33 is a promising target for treatment of atherosclerosis, and numerous studies demonstrate that inhibition of miR-33 increases HDL levels and reduces plaque burden. However, important questions remain about how miR-33 impacts atherogenesis, including whether this protection is primarily due to direct effects on plaque macrophages or regulation of lipid metabolism in the liver. We demonstrate that miR-33 deficiency in Ldlr(-/-) mice promotes obesity, insulin resistance, and hyperlipidemia but does not impact plaque development. We further assess how loss of miR-33 or addition of miR-33b in macrophages and other hematopoietic cells impact atherogenesis. Macrophage-specific loss of miR-33 decreases lipid accumulation and inflammation under hyperlipidemic conditions, leading to reduced plaque burden. Therefore, the pro-atherogenic effects observed in miR-33-deficient mice are likely counterbalanced by protective effects in macrophages, which may be the primary mechanism through which anti-miR-33 therapies reduce atherosclerosis.

Citations

Jun 15, 2018·International Journal of Molecular Sciences·Yuanyuan WeiAndreas Schober
May 10, 2019·Circulation Research·Mireille OuimetEdward A Fisher
Aug 8, 2019·Cardiovascular Research·Francesca FasoloJason L Johnson
Feb 14, 2020·Artificial Cells, Nanomedicine, and Biotechnology·Dan Deng, Hui Liang
Feb 14, 2020·Journal of Biochemical and Molecular Toxicology·Ming CuiZhenlei Xin
Oct 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Tomohiro NishinoKoh Ono
Jul 18, 2018·Frontiers in Cardiovascular Medicine·Anindita DasFadi N Salloum
Jan 17, 2019·BioMed Research International·Yuxiang HuangYongqiang Li
Oct 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·M Mahmood Hussain, Ira J Goldberg
Feb 23, 2019·Expert Review of Gastroenterology & Hepatology·Agostino Di CiaulaPiero Portincasa
Dec 14, 2018·Frontiers in Physiology·John HungAndrew H Baker
Jun 30, 2019·International Journal of Molecular Sciences·Beate FisslthalerIngrid Fleming
Oct 3, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Micaela GliozziVincenzo Mollace
Jan 27, 2021·Proceedings of the National Academy of Sciences of the United States of America·Nathan L PriceCarlos Fernández-Hernando
Jan 27, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Jianguo WuLi Wang
Feb 2, 2021·Annals of the New York Academy of Sciences·Kathryn M CitrinYajaira Suárez
Mar 5, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Milessa Silva AfonsoKathryn J Moore
Dec 1, 2017·Seminars in Cell & Developmental Biology·Abhishek K SinghCarlos Fernández-Hernando
Mar 28, 2021·Nature Reviews. Molecular Cell Biology·Pamela Agbu, Richard W Carthew
Apr 4, 2021·International Journal of Molecular Sciences·Amin JavadifarAmirhossein Sahebkar
Feb 18, 2021·Circulation Research·Milessa Silva AfonsoKathryn J Moore
May 4, 2021·EMBO Molecular Medicine·Nathan L PriceCarlos Fernández-Hernando
May 7, 2021·Oxidative Medicine and Cellular Longevity·Md Sayed Ali SheikhIbrahim A M Abdulhabeeb
May 11, 2021·Current Atherosclerosis Reports·Pablo Fernández-TussyCarlos Fernández-Hernando
Jun 22, 2018·Vascular Pharmacology·Xinbo ZhangCarlos Fernández-Hernando

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.